Tumor lysis syndrome: implications for nursing

Tumor Lysis Syndrome (TLS) is a potential consequence of antineoplastic therapy, causing metabolic disturbances that if left untreated, may result in potentially fatal renal, cardiac, and neurologic complications. Early identification and prompt interventions are necessary to treat the metabolic disturbances of TLS. As more therapies are directed toward ambulatory care and home care settings, identification of patients at risk for potential complications associated with antineoplastic administration is more crucial than ever.